Perceptive Advisors LLC Solid Biosciences Inc. Call Options Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $919 - $2,026	200 New	200 $23,000
Q1 2019 May 15, 2019	SELL	$7.19 - $32.37 $13,193 - $59,398	-1,835 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $39,122 - $85,033	1,835 New	1,835 $14,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.